Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 5/2007

01.05.2007

The Prognostic Significance of Total Lymph Node Harvest in Patients with T2–4N0M0 Colorectal Cancer

verfasst von: Hsiang-Lin Tsai, Chien-Yu Lu, Jan-Sing Hsieh, Deng-Chyang Wu, Chang-Ming Jan, Chee-Yin Chai, Koung Shing Chu, Hon-Man Chan, Jaw-Yuan Wang

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

In patients with radically resected colorectal carcinoma, lymph node involvement is particularly important for a good prognosis and adjuvant therapy. The number of such lymph node recoveries is still controversial, with recommendations ranging from 6 to 17 nodes. The aim of this study is to determine if a specified minimum number of lymph nodes examined per surgical specimen can have any effect on the prognosis of patients who have undergone curative resection for T2–4N0M0 colorectal carcinoma. Between September 1999 and January 2005, a total of 366 patients who underwent radical resection for T2–4N0M0 colorectal carcinoma were retrospectively analyzed in a single institution. All specimen segments were fixed, with node identification performed by sight and palpation. We excluded 186 patients who received postoperative adjuvant chemotherapy via oral or intravenous transmission to prevent possible chemotherapeutic effects on patients’ prognosis; therefore, a total of 180 patients with T2–4N0M0 colorectal carcinoma were enrolled into this study. After the pathological examination, a mean of 12 lymph nodes (range 0–66) was harvested per tumor specimen. No postoperative relapse was found in this group, where the number of examined lymph nodes was 18 or more. Univariate analysis identified the size of the tumor, depth of invasion, grade of tumor, and number of examined lymph nodes, which were significantly correlated with postoperative relapse (all P < 0.05). Meanwhile, both the depth of tumor invasion and the number of harvested lymph nodes were independent predictors for postoperative relapse (P < 0.05). The 5-year overall survival rate of T2–4N0M0 colorectal carcinoma patients who had 18 or more lymph nodes examined was significantly higher than those who had less than 18 nodes examined (P = 0.015). Nodal harvest in patients undergoing radical resection for colorectal carcinoma was highly significant in the current investigation. Our results suggest that harvesting and examining a minimum of 18 lymph nodes per surgical specimen might be taken into consideration for more reliable staging of lymph node-negative colorectal carcinoma.
Literatur
1.
Zurück zum Zitat Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative therapy for primary colon cancers: results from the National Surgical Adjuvant Breast and Bowel Project. J Clin Oncol 1993;11:1879–1887.PubMed Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative therapy for primary colon cancers: results from the National Surgical Adjuvant Breast and Bowel Project. J Clin Oncol 1993;11:1879–1887.PubMed
2.
Zurück zum Zitat Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002;236:416–421.PubMedCrossRef Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002;236:416–421.PubMedCrossRef
3.
Zurück zum Zitat Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies again cytokeratin and CC49. Cancer 1994;73:563–569.PubMedCrossRef Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies again cytokeratin and CC49. Cancer 1994;73:563–569.PubMedCrossRef
4.
Zurück zum Zitat Scott KWM, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989;76:1165–1167.PubMedCrossRef Scott KWM, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989;76:1165–1167.PubMedCrossRef
5.
Zurück zum Zitat Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathologic staging for colorectal cancer: an international documentation system (IDS) and an international comprehensive anatomical terminology (ICAT). J Gastroenterol Hepatol 1991;6:325–344.PubMed Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathologic staging for colorectal cancer: an international documentation system (IDS) and an international comprehensive anatomical terminology (ICAT). J Gastroenterol Hepatol 1991;6:325–344.PubMed
6.
Zurück zum Zitat Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996;106:209–216.PubMed Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996;106:209–216.PubMed
7.
Zurück zum Zitat Fielding LP. Clinical-pathologic staging of large-bowel cancer: a report of the ASCRS Committee. Dis Colon Rectum 1988;31:204–209.PubMedCrossRef Fielding LP. Clinical-pathologic staging of large-bowel cancer: a report of the ASCRS Committee. Dis Colon Rectum 1988;31:204–209.PubMedCrossRef
8.
Zurück zum Zitat Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583–596.PubMedCrossRef Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583–596.PubMedCrossRef
9.
Zurück zum Zitat Fabio C, Annarita P, Vieri B, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 2002;26:384–389.CrossRef Fabio C, Annarita P, Vieri B, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 2002;26:384–389.CrossRef
10.
Zurück zum Zitat Fobnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study. J Gastrointest Surg 2002;6:883–890.CrossRef Fobnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study. J Gastrointest Surg 2002;6:883–890.CrossRef
11.
Zurück zum Zitat International Union Against Cancer. TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss, Inc., 2002. International Union Against Cancer. TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss, Inc., 2002.
12.
Zurück zum Zitat Steup WH, Moriya Y, van de Velde CJ. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer 2002;38:911–918.PubMedCrossRef Steup WH, Moriya Y, van de Velde CJ. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer 2002;38:911–918.PubMedCrossRef
13.
Zurück zum Zitat Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999;23:721–726.PubMedCrossRef Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999;23:721–726.PubMedCrossRef
14.
Zurück zum Zitat Wolmark N, Fisher B, Wieand HS. The prognostic value of the modification of the Dukes C class of colorectal cancer: an analysis of the NSABP trial. Ann Surg 1986;139:846–852. Wolmark N, Fisher B, Wieand HS. The prognostic value of the modification of the Dukes C class of colorectal cancer: an analysis of the NSABP trial. Ann Surg 1986;139:846–852.
15.
Zurück zum Zitat Kubota K, Akasu T, Fujita S, Sugihara K, Moriya Y, Yamamoto S. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas. Hepatogastroenterology 2004;51:142–146.PubMed Kubota K, Akasu T, Fujita S, Sugihara K, Moriya Y, Yamamoto S. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas. Hepatogastroenterology 2004;51:142–146.PubMed
16.
Zurück zum Zitat Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002;26:79–89. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002;26:79–89.
17.
Zurück zum Zitat Petersen VC, Baxter KJ, Love SB, Shepherd NA. Identification of objective pathological prognostic determinants and models of prognosis in Dukes’ B colon cancer. Gut 2002;51:65–69.PubMedCrossRef Petersen VC, Baxter KJ, Love SB, Shepherd NA. Identification of objective pathological prognostic determinants and models of prognosis in Dukes’ B colon cancer. Gut 2002;51:65–69.PubMedCrossRef
18.
Zurück zum Zitat Scott KW, Grace RH, Gibbons P. Five-year follow-up study of the fat clearance technique in colorectal carcinoma. Dis Colon Rectum 1994;37:126–128.PubMedCrossRef Scott KW, Grace RH, Gibbons P. Five-year follow-up study of the fat clearance technique in colorectal carcinoma. Dis Colon Rectum 1994;37:126–128.PubMedCrossRef
19.
Zurück zum Zitat Mukai M, Sato S, Nishida T, et al. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer. Oncol Rep 2003;10:1753–1758.PubMed Mukai M, Sato S, Nishida T, et al. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer. Oncol Rep 2003;10:1753–1758.PubMed
20.
Zurück zum Zitat Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gomez-Fleitas M. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum 1994;37:373–377.PubMedCrossRef Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gomez-Fleitas M. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum 1994;37:373–377.PubMedCrossRef
21.
Zurück zum Zitat Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes’ B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998;83:666–672.PubMedCrossRef Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes’ B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998;83:666–672.PubMedCrossRef
22.
Zurück zum Zitat Wong JH, Severino R, Homnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999;17:2896–2900.PubMed Wong JH, Severino R, Homnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999;17:2896–2900.PubMed
23.
Zurück zum Zitat Canessa CE, Badia F, Socorro F, Fiol V, Hayek G. Anatomic study of the lymph nodes of the mesorectum. Dis Colon Rectum 2001;44:1333–1336.PubMedCrossRef Canessa CE, Badia F, Socorro F, Fiol V, Hayek G. Anatomic study of the lymph nodes of the mesorectum. Dis Colon Rectum 2001;44:1333–1336.PubMedCrossRef
24.
Zurück zum Zitat Leopoldo S, Giovanni B, Domenico I, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005;41:272–279.CrossRef Leopoldo S, Giovanni B, Domenico I, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005;41:272–279.CrossRef
Metadaten
Titel
The Prognostic Significance of Total Lymph Node Harvest in Patients with T2–4N0M0 Colorectal Cancer
verfasst von
Hsiang-Lin Tsai
Chien-Yu Lu
Jan-Sing Hsieh
Deng-Chyang Wu
Chang-Ming Jan
Chee-Yin Chai
Koung Shing Chu
Hon-Man Chan
Jaw-Yuan Wang
Publikationsdatum
01.05.2007
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 5/2007
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-007-0119-x

Weitere Artikel der Ausgabe 5/2007

Journal of Gastrointestinal Surgery 5/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.